Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ · Healthcare
Black Diamond Therapeutics, Inc. Operating Income 2018–2025
Black Diamond Therapeutics, Inc. annual/quarterly operating income history and growth rate from 2018 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Black Diamond Therapeutics, Inc. operating income for the quarter ending March 31, 2026 was -11.3 M, a 120.65% decrease year-over-year.
- Black Diamond Therapeutics, Inc. operating income for the twelve months ending March 31, 2026 was 18.9 M.
- Black Diamond Therapeutics, Inc. annual operating income for 2025 was 12.5 M, a 115.89% decrease from 2024.
- Black Diamond Therapeutics, Inc. annual operating income for 2024 was -78.8 M, a 13.24% increase from 2020.
- Black Diamond Therapeutics, Inc. annual operating income for 2020 was -69.6 M, a 137.18% increase from 2019.
- Black Diamond Therapeutics, Inc. annual operating income for 2019 was -29.3 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Black Diamond Therapeutics, Inc. Operating Income — FAQ
Black Diamond Therapeutics, Inc. (BDTX) operating income over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
What is Black Diamond Therapeutics, Inc.'s operating income?
Black Diamond Therapeutics, Inc. (BDTX) reported operating income of $13M for fiscal 2025.
Where can I see BDTX's operating income history?
The chart and table above show Black Diamond Therapeutics, Inc.'s operating income by year and by quarter, including the growth rate.